Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
COMPLETED
NCT02798471
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
290
Enrollment(s)
140
Study location(s)
INTERVENTIONAL (PHASE3)
Venous Thromboembolism (VTE)
Pulmonary Embolism
Deep Vein Thrombosis (DVT)
TERMINATED
NCT02618577
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
2,608
Enrollment(s)
18
Study location(s)
INTERVENTIONAL (PHASE3)
Atrial High Rate Episodes
COMPLETED
NCT02401815
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
51
Enrollment(s)
6
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Gastrointestinal Stromal Tumors
연구종결
KCT0010330
비타민K비의존성 경구용 항응고제를 사용하는 비판막성 심방세동 환자에서 올메사르탄 병용 사용군 대비 텔미사르탄 병용 사용군의 출혈 위험을 평가하는 후향적 코호트 연구
18,252
Enrollment(s)
1
Study location(s)
관찰연구 (None)
연구종결
KCT0009530
건강한 성인을 대상으로 보중익기탕, 청상견통탕 및 이진탕이 에독사반의 약동학 및 약력학에 미치는 영향을 평가하기 위한 임상시험
30
Enrollment(s)
1
Study location(s)
중재연구 (None)
ACTIVE_NOT_RECRUITING
NCT04132960
Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
186
Enrollment(s)
15
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Tumors
RECRUITING
NCT06551220
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns
800
Enrollment(s)
23
Study location(s)
OBSERVATIONAL (None)
Metastatic Breast Cancer
COMPLETED
NCT05246514
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
72
Enrollment(s)
28
Study location(s)
INTERVENTIONAL (PHASE2)
HER2-mutant Non-Small Cell Lung Cancer
16
17
18
19
20